Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Landmark studies presented at San Antonio Breast Cancer Symposium
January 13th, 2005
The 27th Annual San Antonio Breast Cancer Symposium that took place December 8-11, 2004 included the presentation of several landmark studies that may change the treatment standards for breast cancer. New results from patient trials indicated that aromatase inhibitors are a better option than tamoxifen, the current standard therapy, to prevent recurrence in postmenopausal women with hormone-responsive breast cancer. Other studies showed that radiation therapy may not be necessary for older women, and that a simple blood test may identify women who will benefit from chemotherapy. Aromatase inhibitors deplete circulating estrogen in postmenopausal...
Source: Women's Health Weekly (2005-01-13)
|
